pfe:ExcludingComirnatyAndPaxlovidMember
pfe:BiopharmaSegmentMember
2023-01-01
2023-12-31
0000078003
pfe:PrimaryCareMember
pfe:ExcludingComirnatyAndPaxlovidMember
pfe:BiopharmaSegmentMember
2022-01-01
2022-12-31
0000078003
country:US
2024-01-01
2024-12-31
0000078003
country:US
2023-01-01
2023-12-31
0000078003
country:US
2022-01-01
2022-12-31
0000078003
pfe:InternationalDevelopedMarketsMember
2024-01-01
2024-12-31
0000078003
pfe:InternationalDevelopedMarketsMember
2023-01-01
2023-12-31
0000078003
pfe:InternationalDevelopedMarketsMember
2022-01-01
2022-12-31
0000078003
pfe:InternationalEmergingMarketsMember
2024-01-01
2024-12-31
0000078003
pfe:InternationalEmergingMarketsMember
2023-01-01
2023-12-31
0000078003
pfe:InternationalEmergingMarketsMember
2022-01-01
2022-12-31
0000078003
pfe:NonUnitedStatesMember
us-gaap:GeographicConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2024-12-31
0000078003
pfe:NonUnitedStatesMember
us-gaap:GeographicConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2023-12-31
0000078003
pfe:NonUnitedStatesMember
us-gaap:GeographicConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2022-12-31
0000078003
country:US
us-gaap:GeographicConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2024-01-01
2024-12-31
0000078003
country:US
us-gaap:GeographicConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2022-01-01
2022-12-31
0000078003
country:US
us-gaap:GeographicConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2023-01-01
2023-12-31
0000078003
country:CN
us-gaap:GeographicConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2024-01-01
2024-12-31
0000078003
country:JP
us-gaap:GeographicConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2023-01-01
2023-12-31
0000078003
country:JP
us-gaap:GeographicConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2022-01-01
2022-12-31
0000078003
pfe:PaxlovidEUALabeledMember
2023-12-31
0000078003
pfe:PaxlovidEUALabeledMember
2024-01-01
2024-03-31
0000078003
pfe:PaxlovidEUALabeledMember
2024-01-01
2024-02-29
0000078003
pfe:PaxlovidNDALabeledUSStrategicNationalStockpileMember
2024-09-29
0000078003
pfe:PaxlovidNDALabeledUSStrategicNationalStockpileMember
2024-07-01
2024-09-29
0000078003
pfe:McKessonInc.Member
us-gaap:CustomerConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2024-01-01
2024-12-31
0000078003
pfe:McKessonInc.Member
us-gaap:CustomerConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2023-01-01
2023-12-31
0000078003
pfe:McKessonInc.Member
us-gaap:CustomerConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2022-01-01
2022-12-31
0000078003
pfe:CencoraInc.Member
us-gaap:CustomerConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerMember
2024-01-01
2024-12-31
0000078003
pfe:CencoraInc.Member
us-gaap:CustomerConcentrationRiskMember
us-